Delivery Order 75A50122D00002-75A50126F61021

<p>The Office of the Assistant Secretary for Preparedness and Response issued a delivery order to Glaxosmithkline, LLC on June 13, 2025, with a ceiling value of $491,400 for fill/finish of DOD AS03 adjuvant clinical lot 1006E.</p> <p>Place of performance is Durham, NC. The order is firm fixed price with an ultimate completion date of August 30, 2026. No set-aside was used for this award.</p>

<p>The Office of the Assistant Secretary for Preparedness and Response issued a $15.4 million delivery order to Glaxosmithkline, LLC on February 27, 2024, under IDIQ contract 75A50122D00002 to establish fill/finish activities for AS03 adjuvant to support the COVID-19 federal response in multi-dose vials for the Department of Health and Human Services.</p> <p>Place of performance is Durham, NC. The order carries a firm fixed price and an ultimate completion date of February 21, 2027.</p>

<p>The Office of the Assistant Secretary for Preparedness and Response issued a delivery order to GlaxoSmithKline LLC on June 13, 2025, with a ceiling value of $8.78 million for CGMP adjuvant clinical or commercial scale bulk lot(s). Place of performance is Durham, NC. The order is firm fixed price and has an ultimate completion date of December 12, 2025. No set-aside applies to this delivery order.</p>

The Office of the Assistant Secretary for Preparedness and Response (ASPR) issued a delivery order to Glaxosmithkline, LLC on December 12, 2022, with a ceiling value of $4,680,600.49 under an IDIQ for AS03 adjuvant fill-finish, storage, and stability services. The order's period of performance runs through February 21, 2024. A no-cost modification corrected the period of performance for CLINs 3000 and 6000 and transferred accountability of 5,015,690 vials (50.1 million doses) of AS03 adjuvant...

<p>The Office of the Assistant Secretary for Preparedness and Response issued a delivery order to GlaxoSmithKline LLC on September 30, 2019, with a ceiling value of $976,635.68 under the Pandemic Influenza Preparedness and Response 2016–2021 IDIQ. The order was issued on a firm fixed price basis with no set-aside.</p> <p>Place of performance is Durham, NC. The ultimate completion date is September 30, 2019. The modification P0001 deobligated remaining funds and closed the order.</p>

<p>The Office of the Assistant Secretary for Preparedness and Response issued a delivery order to Glaxosmithkline, LLC on January 9, 2018, with a ceiling value of $2,045,820.60 under the Pandemic Influenza Preparedness and Response 2016-2021 IDIQ. The order has been deobligated and closed as of Modification P00005.</p> <p>Place of performance is Durham, NC 27709. The ultimate completion date was September 22, 2023. This firm fixed price delivery order carried no set-aside.</p>

<p>The Office of the Assistant Secretary for Preparedness and Response (HHS) issued a $94.4 million delivery order to Glaxosmithkline, LLC on May 10, 2024, for medical countermeasures supporting H5 pandemic readiness, influenza preparedness, and emerging disease response under parent contract 75A50122D00002.</p> <p>Place of performance is Durham, NC. The order carries a firm fixed price structure with an ultimate completion date of February 21, 2027. No set-aside applies to this award.</p>

Glaxosmithkline, LLC, doing business as Glaxosmithkline, has been awarded a definitive contract by the Department of the Army to provide GLAXOSMITHKLINE ADJUVANT AS03. Valued at approximately $335.6 million, this firm fixed price contract runs from July 30, 2020 through December 30, 2022 and will be performed in Research Triangle Park, North Carolina. Under the contract, Glaxosmithkline will deliver its GLAXOSMITHKLINE ADJUVANT AS03 product to the Department of the Army in support of the...

<p>The Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, issued a $422,424.85 delivery order to Glaxosmithkline, LLC on February 21, 2024, under IDIQ contract 75A50122D00002 for storage and stability services on vaccine bulk lots from prior contracts during base period year 3.</p> <p>Place of performance is Durham, NC. Period of performance runs through May 21, 2027. The order is firm fixed price with no set-aside designation.</p>

<p>The Office of the Assistant Secretary for Preparedness and Response issued a delivery order to Glaxosmithkline, LLC on April 11, 2022, with a ceiling value of $597,821 for the acquisition of Influenza A/Astrakhan/3212/2020 (H5N8)-like master and working seed lot.</p> <p>Place of performance is Durham, NC. The order is firm fixed price with an ultimate completion date of September 30, 2023. No set-aside was used.</p>